The term “drug kingpin” usually brings to mind cartel leaders with gun-toting subordinates. But the state of Oklahoma uses the term to describe Johnson & Johnson in the context of the opioid addiction crisis. The company denies culpability and points out that it has a less than 1% share of the market in that state.
Millions at Stake: The other opioid makers who were sued by Oklahoma reached settlements under which they’ll collectively pay hundreds of millions of dollars. J&J’s market share was not large, but it supplied the active ingredients that others used to manufacture their products, the attorney ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.